Navigation Links
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
Date:1/7/2008

SAN JOSE, Calif., Jan. 7 /PRNewswire/ -- Tacere Therapeutics, Inc., an RNA interference (RNAi)-based therapeutics developer, announced today that it has entered into a collaboration and license agreement with Pfizer Inc. to develop and commercialize its Hepatitis C virus (HCV) compound, TT-033. The collaboration will focus on completing all necessary studies for submission of an investigational new drug application (IND), as well as clinical development and commercialization of TT-033.

"We are very pleased about forming a collaborative relationship with Pfizer, and are excited about being first in the industry to partner an expressed RNAi drug," said Sara M. Hall, Chief Executive Officer of Tacere. "We have made excellent progress in the research and preclinical development of TT-033, and are very happy to be joined by Pfizer at an important time in the program's development. Pfizer recognizes the potential of this first-in- class approach to provide a novel treatment option for HCV patients and we look forward to working with the team at Pfizer to advance TT-033."

Mike Catelani, Chairman, President and CFO of Tacere, stated, "We look forward to combining Pfizer's and Tacere's complementary capabilities to take TT-033 into the clinic. We are pleased that Pfizer has chosen to work with us in developing this potential single administration RNAi drug to aid in the fight against the global healthcare crisis of HCV."

Under the terms of the agreement, Tacere and Pfizer will form a joint steering committee to oversee preclinical research and development efforts for TT-033. Pfizer will fund all aspects of the collaboration, including the preclinical development work and will have exclusive worldwide rights, excluding all Asian countries, to commercialize products that result from the collaboration.

During the initial phase of the collaboration, Pfizer will provide Tacere with funding in order to complete the necessary IND-enabling studies
'/>"/>

SOURCE Tacere Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... VIEJO, Calif. , Nov. 26, 2014 /PRNewswire/ ... announced that the U.S. Food and Drug Administration ... its New Drug Application (NDA) for AVP-825. AVP-825 ... low-dose sumatriptan powder delivered intranasally utilizing a novel ... the Complete Response letter, and consistent with the ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge has ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ... Johnson (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... can be accessed at: http://investor-edge.com/register . On ... up 0.07%, the Dow Jones Industrial Average edged 0.02% lower, ...
(Date:11/26/2014)... Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... and Chief Executive Officer, will present at the Bank of America ... , , Date: , , , Wednesday, December 3, 2014 ... EST , , , , Location: , , , Boca ... About BioScrip, Inc. BioScrip, Inc. is a ...
Breaking Medicine Technology:Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... Four novel genes that may,significantly increase the ... have been identified by researchers at Massachusetts General,Hospital ... November 7th issue,of American Journal of Human Genetics. ... (AGP) established three years ago to identify,the full ...
... FREMONT, Calif., Oct. 29 Vermillion, Inc.,(OTC Bulletin ... with Quest,Diagnostics to extend the Strategic Alliance Agreement ... enable the companies to continue,work on the development ... The OVA1 test is intended to identify women ...
Cached Medicine Technology:Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 2Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 2Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 4
(Date:11/28/2014)... 2014 Lunadress.co.uk, one of the world’s ... has recently released its fashionable white prom gowns. These ... quality and low price. The company provides a big ... and free shipping for orders over 99 pounds. , ... professional sales representatives if needed. The kind experts will ...
(Date:11/28/2014)... 2014 The report “Poxvirus Infections ... the therapeutic development for Poxvirus Infections, complete with ... drug target, mechanism of action (MoA), route of ... updates, and featured news and press releases. It ... development for Poxvirus Infections and special features on ...
(Date:11/28/2014)... Angelweddingdress.com, a world-famous dress manufacturer and retailer, has ... Styles of Bridesmaid Dresses recently. A big ... free shipping on orders over $150! Those who ... less at the online store please click ... reliable dress supplier in the international market. It ...
(Date:11/28/2014)... Yesterday on November 27th, 2014, Thanksgiving morning, ... and families from 8 different sites throughout Miami-Dade and ... in Florida on Thanksgiving Day. Over 1,400 volunteers worked ... together individual meals via assembly lines and passing them ... includes turkey, stuffing, green beans, mashed potatoes, cranberry sauce, ...
(Date:11/28/2014)... 2014 Pathways Home Health & ... This national movement was created to encourage people to ... local charities and causes. This online event, celebrated ... kickoff of the holiday shopping season. #GivingTuesday is to ... Cyber Monday is to online commerce. , The goal ...
Breaking Medicine News(10 mins):Health News:LunaDress.co.uk: New White LunaDress Prom Gowns Online for Sale Now 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:Blue Color Styles of Bridesmaid Dresses from AngelWeddingDress.com are Available Now With Big Discounts 2Health News:Branches’ 14th Annual Thanksgiving Delivers 6,000+ Meals to Families in Need 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3
... HealthDay Reporter , MONDAY, March 5 (HealthDay News) -- The more ... big screen, the more alcohol they drink themselves, a new study ... 10 to 19 from six European countries -- the largest study ... or more drinks on at least one occasion. Teens who ...
... , MONDAY, March 5 (HealthDay News) -- Babies ... greater risk of developing asthma when compared with children born ... to infants born between the 34th and 37th week of ... an asthma diagnosis by the age of 8 years, despite ...
... available in French . A ... increase in prevalence of Canadian children diagnosed with attention-deficit ... associated with ADHD in school-age children. The study, ... Among Canadian Preschoolers and School-Age Children: 1994-2007, was conducted ...
... study from Case Western Reserve University,s Frances Payne Bolton ... related to quality of life before becoming critically ill. ... a research team that observed, taped and analyzed discussions ... intensive care units (ICUs) at University Hospitals Case Medical ...
... gene that causes adult-onset primary cervical dystonia, an often-painful condition ... team from the Jacksonville, Fla., campus of Mayo Clinic and ... a movement disorder that physicians previously could seldom explain. Their ... . In 1990, a man with a crooked neck ...
... University of Notre Dame,s annual Bengal Bouts student boxing ... Bodies May Be Nourished." The unusual mantra is ... benefit Holy Cross Missions in Bangladesh, part of the ... Dame,s founding religious community. However, this year a large ...
Cached Medicine News:Health News:Drinking Scenes in Movies May Spur Teens to Do the Same 2Health News:Drinking Scenes in Movies May Spur Teens to Do the Same 3Health News:Late Preemie Birth May Be Linked to Higher Asthma Risk 2Health News:Hyperactivity: Increased prevalence of children with ADHD and the use of stimulants 2Health News:CWRU study finds quality-of-life discussions are important for ICU patients 2Health News:Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder 2Health News:Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder 3Health News:Notre Dame's Bengal Bouts participants aid in concussion research 2Health News:Notre Dame's Bengal Bouts participants aid in concussion research 3
... This contact class is ... slit lamps which have a ... and the reduction prism than ... area: fundus / iridocornea. Mirror ...
... Fully Automatic High Speed Pre and Post ... a double-wall autoclave designed to cover a ... operating rooms, as well as private clinics ... designed for sterilization of medical and surgical ...
HRT II is the smallest scanning laser ever, light, portable and ready for telemedicine....
Subjective refraction unit, computer controlled and programmable. Two versions: with and without prisms....
Medicine Products: